1Daniel L, Herr S, John SP, et al. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia, 2003, 17: 576-584.
2Maldonado JR, Starre P, Wysong A. The role of the novel anesthetic agent dexmedetomidine on reduction of the incidence of ICU delirium in postcardiotomy patients. Journal of Psychosomatic Research, 2003, 55 : 150.
3Gepts E, Shafer SL, Camu F, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology, 1995, 83: 1194-1204.
4Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth, 1991,67 : 4148.
5Talke P. Pharmacodynamics of alpha2-adrenoceptor agonists. Bailliere's Clinical Anaesthesiology, 2000, 14: 271-283.
6Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth, 1992, 68: 126-131.
7Scheinin H, Jaakola ML, Sjovall S, et al. Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology, 1993, 78: 1065-1075.
8Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg, 2000, 90: 834-839.
9Mendes GM, Selmi AL, Barbudo-Seimi GR, et al. Effect of dexmedetomidiue as premedicant in cats undergoing propofol-sevoflurane anaesthesia. J Feline Med Surg, 2003, 5: 265-270.
10Klan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in health volunteers : pharmacodynamic and phaimacokinetic interactions. Br J Anaesth, 1999, 83 : 372-380.
